Evidence map›Paper›PMID 40997217›Full record

ArticleScience (New York, N.Y.)2025

Mechanosensitive genomic enhancers potentiate the cellular response to matrix stiffness.

Brian D Cosgrove, Lexi R Bounds, Carson Key Taylor, Alan L Su, Anthony J Rizzo, Alejandro Barrera, Tongyu Sun, Alexias Safi, Lingyun Song, Thomas Whitlow and 7 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Mechanical regulation of cell memory.Nature structural & molecular biology · 2026
    Review
  4. Article
  5. Integrative modeling of the genome structure and dynamics in fission yeast.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. An NFATC4 phospho-switch links matrix stiffness to fibroblast fate.The Journal of clinical investigation · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Brian D Cosgrove *Department of Biomedical Engineering, Duke University, Durham, NC, USA.ORCID 0000-0003-2083-0039
Lexi R Bounds *Department of Biomedical Engineering, Duke University, Durham, NC, USA.ORCID 0000-0002-4734-3743
Carson Key Taylor *Department of Biomedical Engineering, Duke University, Durham, NC, USA.ORCID 0000-0002-9446-1419
Alan L SuDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.ORCID 0009-0005-3406-9270
Anthony J RizzoDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.ORCID 0000-0003-2170-6988
Alejandro BarreraCenter for Advanced Genomic Technologies, Duke University, Durham, NC, USA.ORCID 0000-0001-9244-9822
Tongyu SunDepartment of Cell Biology, Duke University, Durham, NC, USA.
Alexias SafiCenter for Advanced Genomic Technologies, Duke University, Durham, NC, USA.ORCID 0000-0001-6381-4923
Lingyun SongCenter for Advanced Genomic Technologies, Duke University, Durham, NC, USA.ORCID 0000-0003-2271-8067
Thomas WhitlowDepartment of Cell Biology, Duke University, Durham, NC, USA.ORCID 0000-0002-7149-5835
Aleksandra TataDepartment of Cell Biology, Duke University, Durham, NC, USA.ORCID 0000-0003-3270-0485
Nahid IglesiasDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.ORCID 0000-0001-5185-846X
Yarui DiaoCenter for Advanced Genomic Technologies, Duke University, Durham, NC, USA.ORCID 0000-0001-5842-4082
Purushothama Rao TataCenter for Advanced Genomic Technologies, Duke University, Durham, NC, USA.ORCID 0000-0003-4837-0337
Brenton D HoffmanDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.ORCID 0000-0003-2296-1331
Gregory E CrawfordCenter for Advanced Genomic Technologies, Duke University, Durham, NC, USA.ORCID 0000-0001-6106-2772
Charles A GersbachDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.ORCID 0000-0003-1478-4013

Funding

The Duke FUNCTION Center: Pioneering the comprehensive identification of combinatorial noncoding causes of diseaseRM1HG011123 · NHGRI · DUKE UNIVERSITY · PI GREGORY E CRAWFORD, Raluca Gordan · 2020 to 2026
$21.9M
High-Throughput Functional Annotation of Gene Regulatory Elements and Variants Critical to Complex Cellular PhenotypesUM1HG012053 · NHGRI · DUKE UNIVERSITY · PI GREGORY E CRAWFORD, Charles A. Gersbach · 2021 to 2026
$10.7M
Beyond GWAS: High Throughput Functional Genomics & Epigenome Editing to Elucidate the Effects of Genetic Associations for SchizophreniaR01MH125236 · NIMH · DUKE UNIVERSITY · PI CRAWFORD, GREGORY E, GERSBACH, CHARLES A. · 2021 to 2025
$8.1M
Regulatory Mechanisms of CD4+ T Cell DifferentiationUM1HG009428 · NHGRI · DUKE UNIVERSITY · PI CIOFANI, MARIA, CRAWFORD, GREGORY E · 2017 to 2021
$4.6M
Molecular control of a novel transitional cell state in alveolar regenerationR01HL153375 · NHLBI · DUKE UNIVERSITY · PI Purushothama Rao Tata · 2020 to 2026
$3.4M
Cellular crosstalk and molecular mechanisms in the initiation and progression of pulmonary fibrosisR01HL160939 · NHLBI · DUKE UNIVERSITY · PI TATA, PURUSHOTHAMA RAO · 2022 to 2025
$2.1M
Mechanisms of submucosal gland cell mediated airway regenerationR01HL146557 · NHLBI · DUKE UNIVERSITY · PI TATA, PURUSHOTHAMA RAO · 2019 to 2023
$2.0M
Epigenome Editing Technologies for Treating Diverse DiseaseU01AI146356 · NIAID · DUKE UNIVERSITY · PI GERSBACH, CHARLES A. · 2019 to 2022
$1.6M
NHGRI NIH HHS RM1 HG011123NHGRI NIH HHS UM1 HG009428NHGRI NIH HHS UM1 HG012053NHLBI NIH HHS R01 HL146557NHLBI NIH HHS R01 HL153375NHLBI NIH HHS R01 HL160939NIAID NIH HHS U01 AI146356NIMH NIH HHS R01 MH125236
6 · The paper itself

Abstract

Epigenetic control of gene expression and cellular phenotype is influenced by changes in the local microenvironment, yet how mechanical cues precisely influence epigenetic state to regulate transcription remains largely unmapped. In this study, we combined genome-wide epigenome profiling, epigenome editing, and phenotypic and single-cell RNA sequencing CRISPR screening to identify a class of genomic enhancers that responds to the mechanical microenvironment. These "mechanoenhancers" can be preferentially activated on either soft or stiff extracellular matrix contexts and regulate transcription to influence critical cell functions including apoptosis, adhesion, proliferation, and migration. Epigenetic editing of mechanoenhancers reprograms the cellular response to the mechanical microenvironment and modulates the activation of disease-related genes in lung fibroblasts from healthy and fibrotic donors. Epigenetic editing of mechanoenhancers holds potential for precise targeting of mechanically driven diseases.

Indexed as

Enhancer Elements, GeneticEpigenesis, GeneticExtracellular MatrixMechanotransduction, CellularA549 CellsApoptosisCell AdhesionCell MovementCell ProliferationCRISPR-Cas SystemsEpigenomeFibroblastsGene EditingHumansLungPrimary Cell Culture

Identifiers

PMID40997217
PMCPMC13005951

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.